PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 23916504-8 2014 Vortioxetine reversed PCPA-induced memory deficits dose-dependently with a minimal effective dose (MED) <=0.1mg/kg (~80% 5-HT3 receptor occupancy; OR) and <=3.0mg/kg (5-HT1A, 5-HT1B, 5-HT3 receptor occupancy: ~15%, 60%, 95%) in SA. Vortioxetine 0-12 5-hydroxytryptamine receptor 1B Rattus norvegicus 181-187 27106166-1 2016 The antidepressant vortioxetine is a 5-HT3-R, 5-HT7-R and 5-HT1D-R antagonist, 5-HT1B-R partial agonist, 5-HT1A-R agonist, and serotonin (5-HT) transporter (SERT) inhibitor. Vortioxetine 19-31 5-hydroxytryptamine receptor 1B Rattus norvegicus 79-85 25665528-1 2015 RATIONALE: Vortioxetine is a novel multimodal antidepressant that is a 5-HT1B receptor partial agonist, a 5-HT1A receptor agonist, an inhibitor of the serotonin (5-HT) transporter, and a 5-HT1D, 5-HT3, and 5-HT7 receptor antagonist in vitro. Vortioxetine 11-23 5-hydroxytryptamine receptor 1B Rattus norvegicus 71-77 25665528-3 2015 OBJECTIVES: The aim of the present study was to investigate the effects of acute and long-term administration of vortioxetine on the terminal 5-HT1B receptor and the tonic activation of 5-HT1A receptor in the rat hippocampus. Vortioxetine 113-125 5-hydroxytryptamine receptor 1B Rattus norvegicus 142-148 25665528-6 2015 RESULTS: Vortioxetine enhanced the inhibitory effect of the stimulation of the 5-HT bundle at a high, but not low frequency and reversed the inhibitory effect of the 5-HT1B receptor agonist CP 94253. Vortioxetine 9-21 5-hydroxytryptamine receptor 1B Rattus norvegicus 166-172 25665528-10 2015 In addition, vortioxetine decreased the function of terminal 5-HT1B autoreceptor following its sustained administration. Vortioxetine 13-25 5-hydroxytryptamine receptor 1B Rattus norvegicus 61-67 25665528-11 2015 CONCLUSIONS: Desensitization of 5-HT1B autoreceptor and an increase of tonic activation of 5-HT1A receptors in the hippocampus may contribute to the antidepressant effect of vortioxetine. Vortioxetine 174-186 5-hydroxytryptamine receptor 1B Rattus norvegicus 32-38 23916504-12 2014 vortioxetine administration significantly improved memory performance in OR and occupied 95%, 66%, and 9.5% of 5-HT3, 5-HT1B, and 5-HT1A receptors, respectively. Vortioxetine 0-12 5-hydroxytryptamine receptor 1B Rattus norvegicus 118-124